Rheumatoid Arthritis News and Research RSS Feed - Rheumatoid Arthritis News and Research

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.

RA is an autoimmune disease, meaning the immune system, which is usually geared up to fight infection, attacks the lining of the joints, causing them to swell and become stiff and painful. Eventually, the joint itself can become damaged as well as the cartilage and surrounding bone. Any joint can be affected but most commonly the illness involves the hands, feet and wrists.

The condition is more common among women than men and usually affects people between the ages of 40 and 70, although it can affect people of any age.

Symptoms range from mild to severe and can flare-up suddenly and unpredictably, making the condition very difficult to live with.

The exact cause of rheumatoid arthritis is not yet fully understood but some research suggests that viruses and bacteria may be involved. RA cannot be cured but early diagnosis and treatment can help to manage symptoms and prevent disability.
Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

Using a novel approach for imaging the movement of immune cells in living animals, researchers from the Massachusetts General Hospital Center for Immunology and Inflammatory Diseases have identified what appear to be the initial steps leading to joint inflammation in a model of inflammatory arthritis. [More]
New antibody design may pave way for treating diseases affecting the brain

New antibody design may pave way for treating diseases affecting the brain

Immunotherapy has proven to be effective against many serious diseases. But to treat diseases in the brain, the antibodies must first get past the obstacle of the blood-brain barrier. [More]
Georgia Tech researchers find new way to improve treatment for inflammatory diseases

Georgia Tech researchers find new way to improve treatment for inflammatory diseases

Is a treatment only making things better or maybe also making some things a little worse? That can be a nagging question in some medical decisions, where side effects are possible. [More]
TSRI biologists uncover new mechanism behind sense of touch

TSRI biologists uncover new mechanism behind sense of touch

Biologists on the Florida campus of The Scripps Research Institute have discovered a new mechanism that likely underlies how we feel force or touch. Their study suggests that "rafts" of fatty lipids on the cell surface act as compartments to keep certain enzymes from mixing with their binding partners. [More]
Genetic influence on immune system appears to be higher than previously thought

Genetic influence on immune system appears to be higher than previously thought

Nearly three quarters of immune traits are influenced by genes, new research from King's College London reveals. [More]
TSRI scientists develop new tool to uncover molecular details of protein structure

TSRI scientists develop new tool to uncover molecular details of protein structure

Scientists on the Florida campus of The Scripps Research Institute have developed a new tool for studying the molecular details of protein structure. [More]
Researchers uncover two factors that play crucial role in chronic autoimmune disorders

Researchers uncover two factors that play crucial role in chronic autoimmune disorders

Researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have uncovered two factors responsible for the chronic, lifelong nature of autoimmune disorders, which tend to "flare up" intermittently in affected patients. [More]
New TSRI study sheds light on how the brain stores memories

New TSRI study sheds light on how the brain stores memories

A new study led by scientists at The Scripps Research Institute (TSRI) sheds light on how the brain stores memories. [More]
Powerful version of anti-inflammatory molecule may help protect vision in diabetic retinopathy

Powerful version of anti-inflammatory molecule may help protect vision in diabetic retinopathy

A more powerful version of an anti-inflammatory molecule already circulating in our blood may help protect our vision in the face of diabetes. [More]
TSRI scientists develop new approach for understanding diverse effects of endocrine-disruptors

TSRI scientists develop new approach for understanding diverse effects of endocrine-disruptors

Breast cancer researchers from the Florida campus of The Scripps Research Institute (TSRI) have developed a novel approach for identifying how chemicals in the environment--called environmental estrogens--can produce infertility, abnormal reproductive development, including "precocious puberty," and promote breast cancer. [More]
A new strategy to fight prostate cancer

A new strategy to fight prostate cancer

A new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) sheds light on a signaling circuit in cells that drives therapy resistance in prostate cancer. [More]
Arthritis patients more likely to be health detail oriented than health detail avoidant, shows study

Arthritis patients more likely to be health detail oriented than health detail avoidant, shows study

Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Carolina Eshelman School of Pharmacy. [More]
New comprehensive study lists top personal health expenses in the U.S.

New comprehensive study lists top personal health expenses in the U.S.

Just 20 conditions make up more than half of all spending on health care in the United States, according to a new comprehensive financial analysis that examines spending by diseases and injuries. [More]
TSRI scientists shed light on how antiviral drug stops influenza infections

TSRI scientists shed light on how antiviral drug stops influenza infections

A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus. [More]
TSRI scientist receives Outstanding Investigator Grant to focus on memory formation research

TSRI scientist receives Outstanding Investigator Grant to focus on memory formation research

Ron Davis, chair of the Department of Neuroscience on the Florida campus of The Scripps Research Institute has been awarded a $5 million Outstanding Investigator Grant, one of the first of its kind, by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health. [More]
U-M researchers identify gene expression linked to gender differences in autoimmune diseases

U-M researchers identify gene expression linked to gender differences in autoimmune diseases

Women represent nearly 8 out of every 10 people with autoimmune diseases. Although the statistics are well-known, the scientific community is still trying to figure out why women's immune systems are more likely to become overactive and attack their own healthy cells. [More]
New review highlights need to reassess use of biologics for treating rheumatoid arthritis patients

New review highlights need to reassess use of biologics for treating rheumatoid arthritis patients

The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients. [More]
Common bacterium that causes gum infections may trigger rheumatoid arthritis

Common bacterium that causes gum infections may trigger rheumatoid arthritis

Investigators at Johns Hopkins report they have new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory "autoimmune" response characteristic of chronic, joint-destroying rheumatoid arthritis (RA). [More]
Initial rheumatoid arthritis symptoms often invisible to others, survey reveals

Initial rheumatoid arthritis symptoms often invisible to others, survey reveals

Rheumatoid Arthritis is a chronic disease characterized by joint swelling, pain, and stiffness that affects approximately 1.3 million individuals in the U.S. Unlike the more common osteoarthritis, RA is an autoimmune condition in which the body's immune system mistakenly attacks healthy tissue. [More]
Rheumatology and arthritis societies call for more support to improve arthritis treatment in Wales

Rheumatology and arthritis societies call for more support to improve arthritis treatment in Wales

Rheumatology and arthritis societies raise concerns for arthritis services in Wales and call for more support to improve long-term patient outcomes. [More]
Advertisement
Advertisement